ACE Study Principal Investigator: Adverse Childhood Events Impact on Adult Health and Addiction Risks | Vincent Felitti, MD
This presentation is part of the 2020 State of the Art in Addiction Medicine conference which covers an expansion of treatment into correctional health, hospital consultation services and emergency rooms. It will cover how, despite the pandemic, telehealth can reach those who are isolated. It will address the worrisome trends in fentanyl, methamphetamine, tobacco and benzodiazepines use; legalization of cannabis, treatment updates for youth, cannabis and alcohol in pregnant women; and novel treatments such as non-benzodiazepines for alcohol withdrawal and psychedelics for substance use disorders.
Learners cannot sign up for individual lectures, only for the full 2020 State of the Art in Addiction Medicine. Please contact CSAM (firstname.lastname@example.org) if you have any questions about this online educational offering.
Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
- Primary care, psychiatry and other specialty field clinicians who want a better understanding of addiction and to improve their care of patients with unhealthy substance use
- Public policy makers, administrators and advocates who want an understanding of the current state of the field of addiction and its grater implications including towards prevention, access to care, integrated systems of care and healthcare technology
- Other healthcare professionals, including psychologists, therapists, nurses, and addiction counselors, who are involved in the treatment of patients with or at risk of substance use
- Recognize the value of using ACE screening tools in clinical practice.
- Describe an adverse childhood event.
- Improve understanding of how ACE's can lead to adult chronic conditions, especially substance use disorders?
Vincent J. Felitti, MD
Vincent J. Felitti, MD is a 1962 medical graduate of Johns Hopkins, an internist with a background in infectious disease. Founding the Department of Preventive Medicine for Kaiser Permanente in San Diego, California in 1975, that Department provided 1.3 million individual, comprehensive, biopsychosocial medical evaluations to adult members of Kaiser Permanente over a 30-year period. During his 50-year career, he developed major health-risk abatement programs for obesity, smoking cessation, the genetic disease Hemochromatosis, and somatization disorders. Dr. Felitti is Clinical Professor of Medicine at the University of California, co-Principal Investigator of the Adverse Childhood Experiences (ACE) Study, and a Fellow of the American College of Physicians.
DISCLOSURE: No relevant financial relationships to disclose
The California Society of Addiction Medicine (CSAM) is accredited by the California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 0.50 AMA PRA Category 1 Credits™, Physicians should only claim credit commensurate with the extent of their participation in the activity.
Continuing education credit is available for psychologists, therapists, substance use counselors, nurses and physician assistants.
(see additional information on page for parent course)
- 0.50 AMA Category 1
- 0.50 Attendance